MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc.
Your view on MAIA
Overview
What the company does, where it operates, and who runs it.
About MAIA Biotechnology, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Vlad Vitoc
- Headquarters
- 444 West Lake Street, Chicago, IL, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Vlad Vitoc
- Headquarters
- 444 West Lake Street, Chicago, IL, US
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.